title: [Multidrug-resistant bacteria require new treatment options].
abstract: By now multidrug-resistant bacteria are a common cause of infections, especially in immunocompromised patient. These infections have to be treated with last resort antibiotics, such as colistin for the treatment of drug-resistant enterobacteriaceae or acinetobacter spp. Additionally the prevention of infections plays an important role in protecting critically ill patients.
authors.forename: Hardy-Thorsten
authors.initials: HT
authors.lastname: Panknin
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents